[Drug therapy of female urinary incontinence].
D001285:Atropine / Q000627:therapeutic use; D002086:Butylscopolammonium Bromide / Q000627:therapeutic use; D004629:Emepronium / Q000627:therapeutic use; D004809:Ephedrine / Q000627:therapeutic use; D005039:Etilefrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D013331:Strychnine / Q000627:therapeutic use; D014549:Urinary Incontinence / Q000188:drug therapy*; D014550:Urinary Incontinence, Stress / Q000188:drug therapy
D000644:Quaternary Ammonium Compounds; D004629:Emepronium; D002086:Butylscopolammonium Bromide; D001285:Atropine; D004809:Ephedrine; D013331:Strychnine; D005039:Etilefrine
Pharmakologische Behandlung der weiblichen Harninkontinenz.